- Home
- CNO vs LNTH Comparison
CNO vs LNTH Comparison
Compare CNO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNO
- LNTH
- Stock Information
- Founded
- CNO 1979
- LNTH 1956
- Country
- CNO United States
- LNTH United States
- Employees
- CNO N/A
- LNTH N/A
- Industry
- CNO Accident &Health Insurance
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CNO Finance
- LNTH Health Care
- Exchange
- CNO Nasdaq
- LNTH Nasdaq
- Market Cap
- CNO 3.8B
- LNTH 3.8B
- IPO Year
- CNO 1987
- LNTH 2015
- Fundamental
- Price
- CNO $41.25
- LNTH $51.07
- Analyst Decision
- CNO Hold
- LNTH Buy
- Analyst Count
- CNO 5
- LNTH 6
- Target Price
- CNO $43.60
- LNTH $74.50
- AVG Volume (30 Days)
- CNO 554.9K
- LNTH 1.4M
- Earning Date
- CNO 11-03-2025
- LNTH 11-06-2025
- Dividend Yield
- CNO 1.65%
- LNTH N/A
- EPS Growth
- CNO 20.08
- LNTH N/A
- EPS
- CNO 2.98
- LNTH 2.39
- Revenue
- CNO $4,441,500,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- CNO N/A
- LNTH N/A
- Revenue Next Year
- CNO $3.27
- LNTH $1.98
- P/E Ratio
- CNO $13.84
- LNTH $21.34
- Revenue Growth
- CNO N/A
- LNTH 1.95
- 52 Week Low
- CNO $34.63
- LNTH $47.25
- 52 Week High
- CNO $43.20
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- CNO 59.35
- LNTH 36.35
- Support Level
- CNO $39.19
- LNTH $54.76
- Resistance Level
- CNO $42.00
- LNTH $61.92
- Average True Range (ATR)
- CNO 0.87
- LNTH 2.36
- MACD
- CNO 0.08
- LNTH -0.44
- Stochastic Oscillator
- CNO 66.61
- LNTH 4.15
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.